Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (131-140 of 369) with videos related to

Pageof 37
Sort By:
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
European Journal of Gastroenterology & Hepatology|April 1, 1996
Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel diseaseF Kullmann, M Fadaie, V Gross, et al.
Plos One|December 30, 2016
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy StudyEike Steidl, Ulrich Pilatus, Elke Hattingen, et al.
Der Urologe. Ausg. A|July 1, 1994
[Photodynamic diagnosis of urothelial neoplasms after intravesicular instillation of 5-aminolevulinic acid]M Kriegmair, R Baumgartner, R Knüchel, et al.
BMC Neurology|February 18, 2021
Single-shot bevacizumab for cerebral radiation injuryMartin Voss, Katharina J Wenger, Emmanouil Fokas, et al.
Pharmacotherapy|March 13, 2014
Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent gliomaAnna-Luisa Thiepold, Sophie Lemercier, Kea Franz, et al.
Journal of Neuro-Oncology|October 13, 2009
Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolitesR Ackermann, A Semmler, G D Maurer, et al.
Deutsches Arzteblatt International|January 18, 2023
Neurosurgical Interventions for Cerebral Metastases of Solid TumorsNiklas Thon, Philipp Karschnia, Louisa von von Baumgarten, et al.
Journal of Neuro-Oncology|November 4, 2022
High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumorsSophie von Brauchitsch, Adam Strzelczyk, Felix Rosenow, et al.
International Journal of Molecular Sciences|September 13, 2019
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma TreatmentDennis Heinzen, Iris Divé, Nadja I Lorenz, et al.
Pageof 37

Showing results (131-140 of 369) with videos related to

Sort By:
Pageof 37
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
European Journal of Gastroenterology & Hepatology|April 1, 1996
Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel diseaseF Kullmann, M Fadaie, V Gross, et al.
Plos One|December 30, 2016
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy StudyEike Steidl, Ulrich Pilatus, Elke Hattingen, et al.
Der Urologe. Ausg. A|July 1, 1994
[Photodynamic diagnosis of urothelial neoplasms after intravesicular instillation of 5-aminolevulinic acid]M Kriegmair, R Baumgartner, R Knüchel, et al.
BMC Neurology|February 18, 2021
Single-shot bevacizumab for cerebral radiation injuryMartin Voss, Katharina J Wenger, Emmanouil Fokas, et al.
Pharmacotherapy|March 13, 2014
Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent gliomaAnna-Luisa Thiepold, Sophie Lemercier, Kea Franz, et al.
Journal of Neuro-Oncology|October 13, 2009
Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolitesR Ackermann, A Semmler, G D Maurer, et al.
Deutsches Arzteblatt International|January 18, 2023
Neurosurgical Interventions for Cerebral Metastases of Solid TumorsNiklas Thon, Philipp Karschnia, Louisa von von Baumgarten, et al.
Journal of Neuro-Oncology|November 4, 2022
High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumorsSophie von Brauchitsch, Adam Strzelczyk, Felix Rosenow, et al.
International Journal of Molecular Sciences|September 13, 2019
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma TreatmentDennis Heinzen, Iris Divé, Nadja I Lorenz, et al.
Pageof 37